Skip to main content
Orchid Ventures, Inc. logo

Orchid Ventures, Inc. — Investor Relations & Filings

Ticker · ORVRF ISIN · CA68573L1076 LEI · 8945000TK5RMLOVX4I24 CSE Manufacturing
Filings indexed 252 across all filing types
Latest filing 2020-09-21 Regulatory Filings
Country CA Canada
Listing CSE ORVRF

About Orchid Ventures, Inc.

https://www.orchidessentials.com

Orchid Ventures, Inc. is a cannabis innovation company engaged in the design, development, manufacturing, branding, and distribution of branded cannabis vape products and proprietary hardware delivery systems. The company markets the "Orchid Essentials" brand, which includes comprehensive product lines featuring both tetrahydrocannabinol (THC) and cannabidiol (CBD) formulations. A key operational focus is the development of advanced delivery technology. This is executed through its subsidiary, PurTec Delivery Systems, which designs and sells proprietary, patent-pending hardware solutions to the cannabis and CBD sectors throughout North America. The company emphasizes clean product standards and mass-market appeal.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 95% confidence The document is a notice regarding the upcoming Annual & Special Meeting of securityholders, including details such as meeting date, record date, and voting information. It is a formal announcement related to shareholder meeting logistics rather than the meeting materials themselves or voting results. The document is short (1393 characters) and serves as an informational notice rather than a report or detailed filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-21 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release announcing operational and financial progress, including record purchase orders, stock option grants, and management changes such as a COO leave of absence. It also announces an upcoming investor conference call. There are no detailed financial statements or comprehensive financial performance data typical of an earnings release or interim report. The document is not a full annual or quarterly report, nor is it a regulatory filing or certification. It is primarily an update on company performance and management, with a focus on growth and strategic direction, and includes an investor call announcement. This fits best with a Capital/Financing Update (CAP) category, as it discusses growth, purchase orders, stock options, and operational progress relevant to investors and capital markets.
2020-08-07 English
News release - English.pdf
Regulatory Filings
2020-07-09 English
News release - English.pdf
Regulatory Filings
2020-06-09 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing the upcoming launch of new THC products using CELLg8 technology and the appointment of an independent director to the board. It includes detailed background information about the new product, the new director's qualifications, and company background. There are no financial statements, quarterly or annual results, or regulatory filings presented. The document is not a report but an announcement of product launch and management appointment. Therefore, it fits best under Board/Management Information (MANG) due to the announcement of the appointment of an independent director. The document length (8859 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2020-06-03 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Orchid Ventures, Inc. has entered into a licensing agreement to license its Orchid Essentials brand in three states. It details the terms of the agreement, the parties involved, and the strategic business implications. There are no financial statements, regulatory certifications, or detailed financial performance data included. The content focuses on a business transaction related to licensing and brand expansion, which fits the category of Capital/Financing Update (CAP) as it involves a licensing agreement and related financial terms. The document length is 7,716 characters, which is sufficient for a detailed announcement but does not constitute a full financial report or earnings release. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-05-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.